Oruka Therapeutics Inc (ORKA)
23.76
-1.66
(-6.53%)
USD |
NASDAQ |
Nov 14, 16:00
24.01
+0.25
(+1.05%)
After-Hours: 18:16
Oruka Therapeutics Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 899.53M |
| November 12, 2024 | 923.32M |
| November 11, 2024 | 941.52M |
| November 08, 2024 | 943.62M |
| November 07, 2024 | 906.53M |
| November 06, 2024 | 977.22M |
| November 05, 2024 | 943.97M |
| November 04, 2024 | 953.07M |
| November 01, 2024 | 961.47M |
| October 31, 2024 | 989.82M |
| October 30, 2024 | 1.021B |
| October 29, 2024 | 1.059B |
| October 28, 2024 | 1.070B |
| October 25, 2024 | 989.47M |
| October 24, 2024 | 1.049B |
| October 23, 2024 | 1.059B |
| October 22, 2024 | 1.066B |
| October 21, 2024 | 1.077B |
| October 18, 2024 | 1.051B |
| October 17, 2024 | 1.018B |
| October 16, 2024 | 1.025B |
| October 15, 2024 | 983.52M |
| October 14, 2024 | 980.72M |
| October 11, 2024 | 921.22M |
| October 10, 2024 | 919.82M |
| Date | Value |
|---|---|
| October 09, 2024 | 1.006B |
| October 08, 2024 | 972.67M |
| October 07, 2024 | 919.82M |
| October 04, 2024 | 901.28M |
| October 03, 2024 | 891.48M |
| October 02, 2024 | 884.83M |
| October 01, 2024 | 876.08M |
| September 30, 2024 | 867.68M |
| September 27, 2024 | 808.88M |
| September 26, 2024 | 845.28M |
| September 25, 2024 | 844.23M |
| September 24, 2024 | 844.58M |
| September 23, 2024 | 870.13M |
| September 20, 2024 | 884.83M |
| September 19, 2024 | 878.53M |
| September 18, 2024 | 898.13M |
| September 17, 2024 | 936.27M |
| September 16, 2024 | 916.32M |
| September 13, 2024 | 880.98M |
| September 12, 2024 | 774.22M |
| September 11, 2024 | 880.65M |
| September 10, 2024 | 835.37M |
| September 09, 2024 | 833.02M |
| September 06, 2024 | 744.53M |
| September 05, 2024 | 724.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
724.54M
Minimum
Sep 05 2024
1.077B
Maximum
Oct 21 2024
923.92M
Average
919.82M
Median
Oct 07 2024
Enterprise Value Benchmarks
| LENZ Therapeutics Inc | 783.65M |
| TruBridge Inc | 408.40M |
| PetMed Express Inc | 56.96M |
| Streamline Health Solutions Inc | 18.98M |
| R1 RCM Inc | 8.078B |